Previous Conferences

    ————————————————————————————————————————

 

Cambridge Healthtech Institute's (CHI) Eigth annual
Structure-Based Drug Design Conference
June 25-27, 2008, World Trade Center, Boston, MA

www.healthtech.com

    Conference topics will include the following:
    • Structure-based modeling of GPCRs
    • Determination of protein-protein interactions sites
    • Computational-based protein design
    • Hit and lead optimization
    • Accounting for receptor flexibility in ligand binding
    • Challenges of docking and screening
    • Experimental approaches
    • Case studies

     

    ————————————————————————————————————————

American Chemical Society (ACS) 236th National Meeting & Exposition
August 17-21, 2008; Philadelphia, PA
www.acs.org

This conference will offer a robust technical program, including thematic programming around "Chemistry for Health: Catalyzing Translational Research".

    ————————————————————————————————————————

 

Pittcon Conference 2008
March 1-7, 2008 Ernest N. Morial Convention Center New Orleans, LA
www.pittcon.org

Pittcon is the world's largest, most comprehensive Conference and Exposition for laboratory science. All in one place you can:

  • Get a first-hand look at all the latest products and technologies
  • Gain valuable, practical technical knowledge needed to get ahead professionally
  • Exchange ideas and network with thousands of colleagues from around the world

 

    ————————————————————————————————————————

 

Society for Biomolecular Sciences(SBS) Conference 2008
14th Annual Conference & Exhibition April 6-10, 2008; St. Louis, MO
www.sbsonline.org

The theme for the 2008 conference is Enhancing Research Productivity: Quality Tools, Leads & Candidates. Therefore, we have endeavored to include podium sessions that address both high-throughput screening (HTS) and lead characterization/optimization, as well as three sessions that are focused on disease intervention and relevant therapeutic targets, specifically in cancer, inflammation and CNS disorders. High-throughput screening for the discovery of new leads has been in practice for fifteen years in industry and we plan to highlight advances in the development of new therapeutics from these efforts.

    ————————————————————————————————————————

 

Fragment-based Lead Discovery Conference 2008
February 18-20, 2008 San Diego, CA
http://fbld2008.com

Fragment-based Lead Discovery (FBLD) is a technique with demonstrated success in rapid, novel lead generation for drug discovery. Learn FBLD theory, hands-on implementation, and strategies at this interactive and interdisciplinary event.

Learn how to develop tightly binding drug leads at the Fragment-based Lead Discovery (FBLD) 2008 Conference, February 18-20th in San Diego. FBLD uses smaller compounds and libraries to screen drug lead chemical space more thoroughly, leading to more tightly binding compounds. At FBLD 2008, you’ll gain a perspective on Lead Discovery and Optimization from plenary speakers Stephen Fesik and Christopher Lipinski, along with FBLD experts from Abbott, ActiveSight, Astex Therapeutics, Novartis, Plexxikon, Sunesis, Vernalis, and others.

    ————————————————————————————————————————